Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes

Immunobiology

Volumn 206, Issue 4, 2002, Pages 432-440

  Brunner, Cornelia ^a,c   Avots, Andris ^b   Kreth, Hans Wolfgang ^a   Serfling, Edgar ^b   Schuster, Volker ^a  

^a Children's Hospital   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; LYMPHOCYTE MEMBRANE RECEPTOR; PROTEIN TYROSINE KINASE; TYROSINE; AGAMMAGLOBULINAEMIA TYROSINE KINASE; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; B LYMPHOCYTE; CELL LINE; CELL MATURATION; CELL MEMBRANE; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DAUDI CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; CELL FRACTIONATION; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; PHOSPHORYLATION;

ANTIGENS, CD40; B-LYMPHOCYTES; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; ENZYME ACTIVATION; HUMANS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 0036775164     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00192     Document Type: Article

References (29)

1. ROSEN, F. S., M. D. COOPER, and R. J. P. WEDGWOOD. 1984. The primary immunodeficiencies (1). N. Engl. J. Med. 311: 235.
2. SATTERTHWAITE, A. B., and O. N. WITTE. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175: 120.
3. VIHINEN, M., O. BRANDAU, L. J. BRANDEN, S.-P. KWAN, I. LAPPALAINEN, T. LESTER, J. G. NOORDZIJ, H. D. OCHS, J. OLLILA, S. M. PIENAAR, P. RUKONEN, B. K. SAHA, and C. I. E. SMITH. 1998. BTK-base, mutation database for X-linked agammaglobulinemia (XLA). Nucl. Acids Res. 26: 242.
4. HOLINSKI-FEDER, E., M. WEISS, O. BRANDAU, K. B. JEDELE, B. NORE, C. M. BACKESJO, M. VIHINEN, S. R. HUBBART, B. H. BELOHRADSKY, C. I. SMITH, and A. MEINDL. 1998. Mutation screening of the Btk gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics 101: 276.
5. BYKOWSKY, M. J., R. N. HAIRE, Y. OHTA, H. TANG, S. S. SUNG, E. S. VEKSLER, J. M. GREENE, S. M. FU, G. W. LITMAN, and K. E. SULLIVAN. 1996. Discordant phenotype in siblings with X-linked agammaglobulinemia. Am. J. Hum. Genet. 58: 477.
6. KORNFELD, S. J., R. N. HAIRE, S. J. STRONG, E. N. BRIGINO, H. TANG, S. S. SUNG, S. M. FU, and G. W. LITMAN. 1997. Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family. J. Allergy Clin. Immunol. 100: 702.
7. CAMPANA, D., J. FARRANT, N. INAMDAR, A. D. WEBSTER, and G. JANOSSY. 1990. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 145: 1675.
8. RAWLINGS, D. J., D. C. SAFFRAN, S. TSUKADA, D. A. LARGAESPADA, J. C. GRIMALDI, L. COHEN, R. N. MOHR, J. F. BAZAN, M. HOWARD, N. G. COPELAND, N. A. JENKINS, and O. N. WITTE. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261: 358.
9. THOMAS, J. P., P. SIDERAS, C. I. E. SMITH, I. VORECHOVSKY, V. CHAPMAN, and W. E. PAUL. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261: 355.
10. KHAN, W. N., F. W. ALT, R. M. GERSTEIN, B. A. MALYNN, I. LARSSON, G. RATHBUN, L. DAVIDSON, S. MÜLLER, A. B. KANTOR, L. A. HERZENBERG, F. S. ROSEN, and P. SIDERAS. 1995. Defective B cell development and function in Btk-deficient mice. Immunity 3: 283.
11. KERNER, J. D., M. W. APPLEBY, R. N. MOHR, S. CHIEN, D. J. RAWLINGS, C. R. MALISZEWSKI, O. N. WITTE, and R. M. PERLMUTTER. 1995. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 3: 301.
12. HENDRIKS, R. W., de BRUIJN, M. F., A. MAAS, G. M. GINGJAN, A. KARIS, and F. GROSVELD. 1996. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15: 4862.
13. KUROSAKI, T., and S. TSUKADA. 2000. BLNK: connekting Syk and Btk to calcium signals. Immunity 12: 1.
14. KHAN, W. N., A. NILSSON, E. MIZOGUCHI, E. CASTIGLI, J. FORSELL, A. K. BHAN, R. GEHA, P. SIDERAS, and F. W. ALT. 1997. Impaired B cell maturation in mice lacking Bruton's tyrosine kinase (Btk) and CD40. Int. Immunol. 9: 395.
15. OKA, Y., A. G. ROLINK, J. ANDERSSON, M. KAMANAKA, J. UCHIDA, T. YASUI, KISHIMOTO, T., H. KIKUTANI, and F. MELCHERS. 1996. Profound reduction of mature B cell numbers, reactivities and serum Ig levels in mice which simultaneously carry the XID and CD40 deficiency genes, Int. Immunol. 8: 1675.
16. GRUMONT R. J., and S. GERONDAKIS. 1994. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 12: 1321.
17. LIOU H. C., W. C. SHA, M. L. SCOTT, and D. BALTIMORE. 1994. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 8: 5349.
18. KISTLER B, A. ROLINK, R. MARIENFELD, M. NEUMANN, and T. WIRTH. 1998. Induction of nuclear factor-kappa B during primary B cell differentiation.J Immunol. 160: 2308.
19. NISITANI, S., R. M. KATO, D. J. RAWLINGS, O. N. WITTE, and M. WAHL. 1999. In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 96: 2221.
20. GUINAMARD, R., M. FOUGEREAU, and P. SECKINGER. 1997. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS. Scand. J. Immunol. 45: 587.
21. KAWAKAMI, Y., L. YAO, T. MIURA, S. TSUKADA, O. N. WITTE, and T. KAWAKAMI. 1994. Tyrosine phosphorylation and activation of Bruton's tyrosine kinase upon Fc epsilon RI cross-linking. Mol. Cell. Biol 14: 5108.
22. KLAUS, G. G., M. S. CHOI, E. W. LAM, C. JOHNSON-LEGER, and J. CLIFF. 1997. CD40: a povital receptor in the determination of life/death decisions in B lymphocytes. Int. Rev. Immunol. 15: 5.
23. YANG, W., S. N. MALEK, and S. DESIDERIO. 1995. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo. J. Biol. Chem. 270: 20832.
24. CHENG, G., Z. N. YE, and D. BALTIMORE. 1994. Binding of Bruton's tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction. Proc. Natl. Acad. Sci. USA 91: 8152.
25. RAWLINGS, D. J., A. M. SCHARENBERG, H. PARK, M. I. WAHL, S. LIN, R. M. KATO, A. C. FLUCKIGER, O. N. WITTE, and J. P. KINET. 1996. Activation of BTK by a phosphorylation mechanism initiated by SRC familiy kinases. Science 271: 822.
26. PARK, H., M. I. WAHL, D. E. AFAR, C. W. TURCK, D. J. RAWLINGS, C. TAM, A. M. SCHARENBERG, J. P. KINET, and O. N. WITTE. 1996. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4: 515.
27. FARIS, M., F. GASKIN, T. PARSON, and S. M. FU. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein. J. Exp. Med. 179: 1923.
28. ANDERSON, J. S., M. TEUTSCH, Z. DONG, and H. H. WORTIS. 1996. An essential role of Bruton's (corrected) tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93: 10966.
29. SANTOS-ARGUMEDO, L., F. E. LUND, A. W. HEATH, N. SOLVASON, W. W. WU, C. GRIMALDI, R. M. E. PARKHOUSE, and M. HOWARD. 1995. CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regulator of CD38 induced signal transduction. Int. Immunol. 7: 163.